Publications by authors named "Mark Tannenbaum"

Claim this Profile
R
Renal impairment and mortality in patients with STEMI and cardiogenic shock/cardiac arrest.
Gautam R Shroff, Santiago Garcia, Christian Schmidt, Brynn Okeson, Edward Tannenbaum, Mark Tannenbaum

Catheter Cardiovasc Interv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis.
Muhammad Junaid Ahsan, Soban Ahmad, Azka Latif, Noman Lateef, Mohammad Zoraiz Ahsan, Mark Tannenbaum

Eur Heart J Qual Care Clin Outcomes· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STEMI: Considerations for Left Main Culprit Lesions.
Ameera Ahmed, Frank V Aguirre, Jenny Chambers, Scott W Sharkey, Mark A Tannenbaum

Curr Cardiol Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetic Patients Who Present With ST-Elevation Myocardial Infarction.
Michael Megaly, Christian W Schmidt, Marshall W Dworak, Ross Garberich, Larissa Stanberry, Mark Tannenbaum

Cardiovasc Revasc Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Long-Term Outcomes of Stroke in Patients Presenting With ST-Segment Elevation-Myocardial Infarction: Insights From the Midwest STEMI Consortium.
Michael Megaly, Mehmet Yildiz, Edward Tannenbaum, Brynn Okeson, Marshall W Dworak, Mark Tannenbaum

J Am Heart Assoc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Artery Fistulae in Adult: Two Decades of Experience in Clinical Presentation, Angiographic Feature, and Management.
Tuncay Taskesen, Kofi Osei, Russell Hamilton, Justin Ugwu, Daniel Shivapour, Mark Tannenbaum

Int J Angiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with ST-Segment Elevation Acute Myocardial Infarction.
Judit Karacsonyi, Christian W Schmidt, Brynn K Okeson, Santiago Garcia, Timothy D Henry, Mark Tannenbaum

Am J Cardiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
Santiago Garcia, Larissa Stanberry, Christian Schmidt, Scott Sharkey, Michael Megaly, Mark Tannenbaum

Catheter Cardiovasc Interv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary artery aneurysm presenting as acute coronary syndrome: two case reports and a review of the literature.
Tuncay Taskesen, Kofi Osei, Justin Ugwu, Russell Hamilton, Mark Tannenbaum

J Thromb Thrombolysis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Findings From the North American COVID-19 Myocardial Infarction Registry.
Santiago Garcia, Payam Dehghani, Cindy Grines, Laura Davidson, Keshav R Nayak, Mark Tannenbaum

J Am Coll Cardiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Midwest ST-Elevation Myocardial Infarction Consortium: Design and Rationale.
Mehmet Yildiz, Scott Sharkey, Frank V Aguirre, Mark Tannenbaum, Ross Garberich

Cardiovasc Revasc Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.
Santiago Garcia, Mazen S Albaghdadi, Perwaiz M Meraj, Christian Schmidt, Ross Garberich, Mark Tannenbaum

J Am Coll Cardiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are the results of a regional ST-elevation myocardial infarction system reproducible?
Lindsay G Smith, Sue Duval, Mark A Tannenbaum, Susan Johnson Brown, Anil K Poulose

Am J Cardiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
Nobuaki Suzuki, Dominick J Angiolillo, Mark A Tannenbaum, Mitchell H Driesman, Conrad Smith

Catheter Cardiovasc Interv· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).
Marco A Costa, Dominick J Angiolillo, Mark Tannenbaum, Mitchell Driesman, Alan Chu

Am J Cardiol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Paul S Teirstein, John Kao, Matthew Watkins, Mark A Tannenbaum, Nathan Laufer

Am J Cardiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience.
Warren J Cantor, James E Tcheng, James C Blankenship, J Conor O'Shea, Karen S Pieper, Mark A Tannenbaum

J Invasive Cardiol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
A Michael Lincoff, John A Bittl, Neal S Kleiman, Ian J Sarembock, J Daniel Jackman, Mark A Tannenbaum

Am J Cardiol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.
Alexandra J Lansky, Ricardo A Costa, Gary S Mintz, Yoshihiro Tsuchiya, Mark Midei, Mark A Tannenbaum

Circulation· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis